Fresenius SE Pre-Tax Income 2016-2024 | FSNUY

Fresenius SE annual/quarterly pre-tax income history and growth rate from 2016 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Fresenius SE pre-tax income for the quarter ending June 30, 2024 was $0.170B, a 56.53% decline year-over-year.
  • Fresenius SE pre-tax income for the twelve months ending June 30, 2024 was $0.340B, a 85.62% decline year-over-year.
  • Fresenius SE annual pre-tax income for 2023 was $0.774B, a 73.9% decline from 2022.
  • Fresenius SE annual pre-tax income for 2022 was $2.965B, a 31.38% decline from 2021.
  • Fresenius SE annual pre-tax income for 2021 was $4.321B, a 1.51% increase from 2020.
Fresenius SE Annual Pre-Tax Income
(Millions of US $)
2023 $774
2022 $2,965
2021 $4,321
2020 $4,256
2019 $4,381
2018 $5,508
2017 $4,451
2016 $4,144
2015 $3,622
Fresenius SE Quarterly Pre-Tax Income
(Millions of US $)
2024-06-30 $170
2024-03-31 $449
2023-12-31 $-548
2023-09-30 $268
2023-06-30 $391
2023-03-31 $662
2022-12-31 $558
2022-09-30 $751
2022-06-30 $776
2022-03-31 $880
2021-12-31 $1,149
2021-09-30 $1,040
2021-06-30 $1,084
2021-03-31 $1,048
2020-12-31 $1,042
2020-09-30 $1,121
2020-06-30 $1,053
2020-03-31 $1,040
2019-12-31 $1,204
2019-09-30 $1,064
2019-06-30 $1,055
2019-03-31 $1,057
2018-12-31 $1,243
2018-09-30 $1,043
2018-06-30 $2,132
2018-03-31 $1,090
2017-12-31 $1,110
2017-09-30 $1,118
2017-06-30 $1,094
2017-03-31 $1,129
2016-12-31 $1,184
2016-09-30 $1,040
2016-06-30 $1,030
2016-03-31 $890
2015-12-31 $7,951
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.458B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00